Cancer diagnosis frequently requires imaging studies that in many cases use small amounts of radiation.
This report aims to provide a comprehensive presentation of the global market for Emerging Cancer Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Emerging Cancer Diagnostics. This report contains market size and forecasts of Emerging Cancer Diagnostics in global, including the following market information:
Global Emerging Cancer Diagnostics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Emerging Cancer Diagnostics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Men Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Emerging Cancer Diagnostics include Abbott Laboratories, Danaher, Agilent Technologies, AstraZeneca, BD, Biocept, Illumina, Luminex and NeoGenomics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Emerging Cancer Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Emerging Cancer Diagnostics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Emerging Cancer Diagnostics Market Segment Percentages, by Type, 2022 (%)
Men
Women
Global Emerging Cancer Diagnostics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Emerging Cancer Diagnostics Market Segment Percentages, by Application, 2022 (%)
Blood Cancer
Prostate Cancer
Breast Cancer
Lung Cancer
Others
Global Emerging Cancer Diagnostics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Emerging Cancer Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Emerging Cancer Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Emerging Cancer Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Danaher
Agilent Technologies
AstraZeneca
BD
Biocept
Illumina
Luminex
NeoGenomics
QIAGEN
Thermo Fisher Scientific
Outline of Major Chapters:
Chapter 1: Introduces the definition of Emerging Cancer Diagnostics, market overview.
Chapter 2: Global Emerging Cancer Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Emerging Cancer Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Emerging Cancer Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Emerging Cancer Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Emerging Cancer Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Emerging Cancer Diagnostics Overall Market Size
2.1 Global Emerging Cancer Diagnostics Market Size: 2022 VS 2029
2.2 Global Emerging Cancer Diagnostics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Emerging Cancer Diagnostics Players in Global Market
3.2 Top Global Emerging Cancer Diagnostics Companies Ranked by Revenue
3.3 Global Emerging Cancer Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Emerging Cancer Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Emerging Cancer Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Emerging Cancer Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Emerging Cancer Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Emerging Cancer Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Emerging Cancer Diagnostics Market Size Markets, 2022 & 2029
4.1.2 Men
4.1.3 Women
4.2 By Type - Global Emerging Cancer Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Emerging Cancer Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Emerging Cancer Diagnostics Revenue, 2024-2029
4.2.3 By Type - Global Emerging Cancer Diagnostics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Emerging Cancer Diagnostics Market Size, 2022 & 2029
5.1.2 Blood Cancer
5.1.3 Prostate Cancer
5.1.4 Breast Cancer
5.1.5 Lung Cancer
5.1.6 Others
5.2 By Application - Global Emerging Cancer Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Emerging Cancer Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Emerging Cancer Diagnostics Revenue, 2024-2029
5.2.3 By Application - Global Emerging Cancer Diagnostics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Emerging Cancer Diagnostics Market Size, 2022 & 2029
6.2 By Region - Global Emerging Cancer Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Emerging Cancer Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Emerging Cancer Diagnostics Revenue, 2024-2029
6.2.3 By Region - Global Emerging Cancer Diagnostics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Emerging Cancer Diagnostics Revenue, 2018-2029
6.3.2 US Emerging Cancer Diagnostics Market Size, 2018-2029
6.3.3 Canada Emerging Cancer Diagnostics Market Size, 2018-2029
6.3.4 Mexico Emerging Cancer Diagnostics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Emerging Cancer Diagnostics Revenue, 2018-2029
6.4.2 Germany Emerging Cancer Diagnostics Market Size, 2018-2029
6.4.3 France Emerging Cancer Diagnostics Market Size, 2018-2029
6.4.4 U.K. Emerging Cancer Diagnostics Market Size, 2018-2029
6.4.5 Italy Emerging Cancer Diagnostics Market Size, 2018-2029
6.4.6 Russia Emerging Cancer Diagnostics Market Size, 2018-2029
6.4.7 Nordic Countries Emerging Cancer Diagnostics Market Size, 2018-2029
6.4.8 Benelux Emerging Cancer Diagnostics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Emerging Cancer Diagnostics Revenue, 2018-2029
6.5.2 China Emerging Cancer Diagnostics Market Size, 2018-2029
6.5.3 Japan Emerging Cancer Diagnostics Market Size, 2018-2029
6.5.4 South Korea Emerging Cancer Diagnostics Market Size, 2018-2029
6.5.5 Southeast Asia Emerging Cancer Diagnostics Market Size, 2018-2029
6.5.6 India Emerging Cancer Diagnostics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Emerging Cancer Diagnostics Revenue, 2018-2029
6.6.2 Brazil Emerging Cancer Diagnostics Market Size, 2018-2029
6.6.3 Argentina Emerging Cancer Diagnostics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Emerging Cancer Diagnostics Revenue, 2018-2029
6.7.2 Turkey Emerging Cancer Diagnostics Market Size, 2018-2029
6.7.3 Israel Emerging Cancer Diagnostics Market Size, 2018-2029
6.7.4 Saudi Arabia Emerging Cancer Diagnostics Market Size, 2018-2029
6.7.5 UAE Emerging Cancer Diagnostics Market Size, 2018-2029
7 Emerging Cancer Diagnostics Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Emerging Cancer Diagnostics Major Product Offerings
7.1.4 Abbott Laboratories Emerging Cancer Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 Danaher
7.2.1 Danaher Company Summary
7.2.2 Danaher Business Overview
7.2.3 Danaher Emerging Cancer Diagnostics Major Product Offerings
7.2.4 Danaher Emerging Cancer Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Danaher Key News & Latest Developments
7.3 Agilent Technologies
7.3.1 Agilent Technologies Company Summary
7.3.2 Agilent Technologies Business Overview
7.3.3 Agilent Technologies Emerging Cancer Diagnostics Major Product Offerings
7.3.4 Agilent Technologies Emerging Cancer Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Agilent Technologies Key News & Latest Developments
7.4 AstraZeneca
7.4.1 AstraZeneca Company Summary
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca Emerging Cancer Diagnostics Major Product Offerings
7.4.4 AstraZeneca Emerging Cancer Diagnostics Revenue in Global Market (2018-2023)
7.4.5 AstraZeneca Key News & Latest Developments
7.5 BD
7.5.1 BD Company Summary
7.5.2 BD Business Overview
7.5.3 BD Emerging Cancer Diagnostics Major Product Offerings
7.5.4 BD Emerging Cancer Diagnostics Revenue in Global Market (2018-2023)
7.5.5 BD Key News & Latest Developments
7.6 Biocept
7.6.1 Biocept Company Summary
7.6.2 Biocept Business Overview
7.6.3 Biocept Emerging Cancer Diagnostics Major Product Offerings
7.6.4 Biocept Emerging Cancer Diagnostics Revenue in Global Market (2018-2023)
7.6.5 Biocept Key News & Latest Developments
7.7 Illumina
7.7.1 Illumina Company Summary
7.7.2 Illumina Business Overview
7.7.3 Illumina Emerging Cancer Diagnostics Major Product Offerings
7.7.4 Illumina Emerging Cancer Diagnostics Revenue in Global Market (2018-2023)
7.7.5 Illumina Key News & Latest Developments
7.8 Luminex
7.8.1 Luminex Company Summary
7.8.2 Luminex Business Overview
7.8.3 Luminex Emerging Cancer Diagnostics Major Product Offerings
7.8.4 Luminex Emerging Cancer Diagnostics Revenue in Global Market (2018-2023)
7.8.5 Luminex Key News & Latest Developments
7.9 NeoGenomics
7.9.1 NeoGenomics Company Summary
7.9.2 NeoGenomics Business Overview
7.9.3 NeoGenomics Emerging Cancer Diagnostics Major Product Offerings
7.9.4 NeoGenomics Emerging Cancer Diagnostics Revenue in Global Market (2018-2023)
7.9.5 NeoGenomics Key News & Latest Developments
7.10 QIAGEN
7.10.1 QIAGEN Company Summary
7.10.2 QIAGEN Business Overview
7.10.3 QIAGEN Emerging Cancer Diagnostics Major Product Offerings
7.10.4 QIAGEN Emerging Cancer Diagnostics Revenue in Global Market (2018-2023)
7.10.5 QIAGEN Key News & Latest Developments
7.11 Thermo Fisher Scientific
7.11.1 Thermo Fisher Scientific Company Summary
7.11.2 Thermo Fisher Scientific Business Overview
7.11.3 Thermo Fisher Scientific Emerging Cancer Diagnostics Major Product Offerings
7.11.4 Thermo Fisher Scientific Emerging Cancer Diagnostics Revenue in Global Market (2018-2023)
7.11.5 Thermo Fisher Scientific Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Emerging Cancer Diagnostics Market Opportunities & Trends in Global Market
Table 2. Emerging Cancer Diagnostics Market Drivers in Global Market
Table 3. Emerging Cancer Diagnostics Market Restraints in Global Market
Table 4. Key Players of Emerging Cancer Diagnostics in Global Market
Table 5. Top Emerging Cancer Diagnostics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Emerging Cancer Diagnostics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Emerging Cancer Diagnostics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Emerging Cancer Diagnostics Product Type
Table 9. List of Global Tier 1 Emerging Cancer Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Emerging Cancer Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Emerging Cancer Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Emerging Cancer Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Emerging Cancer Diagnostics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Emerging Cancer Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Emerging Cancer Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Emerging Cancer Diagnostics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Emerging Cancer Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Emerging Cancer Diagnostics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Emerging Cancer Diagnostics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Emerging Cancer Diagnostics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Emerging Cancer Diagnostics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Emerging Cancer Diagnostics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Emerging Cancer Diagnostics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Emerging Cancer Diagnostics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Emerging Cancer Diagnostics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Emerging Cancer Diagnostics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Emerging Cancer Diagnostics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Emerging Cancer Diagnostics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Emerging Cancer Diagnostics Revenue, (US$, Mn), 2024-2029
Table 30. Abbott Laboratories Company Summary
Table 31. Abbott Laboratories Emerging Cancer Diagnostics Product Offerings
Table 32. Abbott Laboratories Emerging Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 33. Abbott Laboratories Key News & Latest Developments
Table 34. Danaher Company Summary
Table 35. Danaher Emerging Cancer Diagnostics Product Offerings
Table 36. Danaher Emerging Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 37. Danaher Key News & Latest Developments
Table 38. Agilent Technologies Company Summary
Table 39. Agilent Technologies Emerging Cancer Diagnostics Product Offerings
Table 40. Agilent Technologies Emerging Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 41. Agilent Technologies Key News & Latest Developments
Table 42. AstraZeneca Company Summary
Table 43. AstraZeneca Emerging Cancer Diagnostics Product Offerings
Table 44. AstraZeneca Emerging Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 45. AstraZeneca Key News & Latest Developments
Table 46. BD Company Summary
Table 47. BD Emerging Cancer Diagnostics Product Offerings
Table 48. BD Emerging Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 49. BD Key News & Latest Developments
Table 50. Biocept Company Summary
Table 51. Biocept Emerging Cancer Diagnostics Product Offerings
Table 52. Biocept Emerging Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 53. Biocept Key News & Latest Developments
Table 54. Illumina Company Summary
Table 55. Illumina Emerging Cancer Diagnostics Product Offerings
Table 56. Illumina Emerging Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 57. Illumina Key News & Latest Developments
Table 58. Luminex Company Summary
Table 59. Luminex Emerging Cancer Diagnostics Product Offerings
Table 60. Luminex Emerging Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 61. Luminex Key News & Latest Developments
Table 62. NeoGenomics Company Summary
Table 63. NeoGenomics Emerging Cancer Diagnostics Product Offerings
Table 64. NeoGenomics Emerging Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 65. NeoGenomics Key News & Latest Developments
Table 66. QIAGEN Company Summary
Table 67. QIAGEN Emerging Cancer Diagnostics Product Offerings
Table 68. QIAGEN Emerging Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 69. QIAGEN Key News & Latest Developments
Table 70. Thermo Fisher Scientific Company Summary
Table 71. Thermo Fisher Scientific Emerging Cancer Diagnostics Product Offerings
Table 72. Thermo Fisher Scientific Emerging Cancer Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 73. Thermo Fisher Scientific Key News & Latest Developments
List of Figures
Figure 1. Emerging Cancer Diagnostics Segment by Type in 2022
Figure 2. Emerging Cancer Diagnostics Segment by Application in 2022
Figure 3. Global Emerging Cancer Diagnostics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Emerging Cancer Diagnostics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Emerging Cancer Diagnostics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Emerging Cancer Diagnostics Revenue in 2022
Figure 8. By Type - Global Emerging Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 9. By Application - Global Emerging Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 10. By Type - Global Emerging Cancer Diagnostics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Emerging Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 12. By Application - Global Emerging Cancer Diagnostics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Emerging Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 14. By Region - Global Emerging Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 15. By Country - North America Emerging Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 16. US Emerging Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Emerging Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Emerging Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Emerging Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 20. Germany Emerging Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 21. France Emerging Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Emerging Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Emerging Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Emerging Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Emerging Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Emerging Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Emerging Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 28. China Emerging Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Emerging Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Emerging Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Emerging Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 32. India Emerging Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Emerging Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 34. Brazil Emerging Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Emerging Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Emerging Cancer Diagnostics Revenue Market Share, 2018-2029
Figure 37. Turkey Emerging Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Emerging Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Emerging Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Emerging Cancer Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 41. Abbott Laboratories Emerging Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Danaher Emerging Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Agilent Technologies Emerging Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. AstraZeneca Emerging Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. BD Emerging Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Biocept Emerging Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Illumina Emerging Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Luminex Emerging Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. NeoGenomics Emerging Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. QIAGEN Emerging Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Thermo Fisher Scientific Emerging Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
